Clinical Trial Update: PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating treatment optimization for metastatic castration-resistant prostate cancer using analysis of circulating tumor DNA. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING